The stimulatory effect of insulin-like growth factor-1 on the proliferation, differentiation, and mineralisation of osteoblastic cells from Holstein cattle

Veterinary Journal

Volumn 179, Issue 3, 2009, Pages 430-436

  Li, Su Hua ^a   Guo, Ding Zong ^a   Li, Bing ^b   Yin, Hong Bin ^a   Li, Jia Kui ^a   Xiang, Jing Mei ^c   Deng, Gan Zhen ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^b Shenzhen Entry Exit Inspection and Quarantine Bureau   (China)

^c Hubei Vocational College of Bio technology   (China)

Author keywords

Chinese Holstein; Insulin like growth factor 1; Metabolic bone disease; Osteoblasts

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; OSTEOCALCIN; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BONE DEVELOPMENT; BONE MINERALIZATION; CATTLE; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; IN VITRO STUDY; METABOLIC BONE DISEASE; NONHUMAN; OSTEOBLAST; RADIOIMMUNOASSAY;

ANIMALS; BONE AND BONES; BONE DENSITY; BONE DEVELOPMENT; CALCIFICATION, PHYSIOLOGIC; CATTLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; INSULIN-LIKE GROWTH FACTOR I; OSTEOBLASTS;

ANIMALIA; BOS;

EID: 58949084059     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2007.10.026     Document Type: Article

References (42)

1. Bellows C.G., Aubin J.E., Heersche J.N.M., and Antosz M.E. Mineralised bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcified Tissue International 38 (1986) 143-154
2. Canalis E., McCarthy T., and Centrella M. Isolation of growth factors from adult bovine bone. Calcified Tissue International 43 (1988) 346-351
3. Chang Y.L., Stanford C.M., and Keller J.C. Calcium and phosphate supplementation promotes bone cell mineralisation: implications for hydroxyapatite (HA)-enhanced bone formation. Journal of Biomedical Materials Research 52 (2000) 270-278
4. Collignon H., Davicco M.J., and Barlet J.P. Isolation of cells from ovine fetal long bone and characterisation of their osteoblastic activities during in vitro mineralisation. Archives of Physiology and Biochemistry 105 (1997) 158-166
5. Cramer A.D., Rogers E.R., and Parker J.W. The Giemsa stain for tissue sections: an improved method. American Journal of Clinical Pathology 60 (1973) 148-156
6. Davicco M.J., Remond B., Jabet S., and Barlet J.P. Plasma osteocalcin concentrations in cows around parturition. The influence of a regular versus a very short dry period. Reproduction, Nutrition, Development 32 (1992) 313-319
7. Delaney A.M., Pash J., and Canalis E. Cellular and clinical perspectives on skeletal insulin-like growth factor-1. Journal of Cellular Biochemistry 55 (1994) 328-333
8. Delmas P.D. Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease. Endocrinology and Metabolism Clinics of North America 19 (1990) 1-18
9. Delmas P.D. Biochemical markers of bone turnover. Journal of Bone and Mineral Research 8 (1993) S549-S555
10. Eriksen E.F., Charles P., Melsen F., Mosekilde L., Risteli L., and Risteli J. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. Journal of Bone and Mineral Research 8 (1993) 127-132
11. Ernst M., and Rodan G.A. Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3. Endocrinology 127 (1990) 807-814
12. Fiedler J., Brill C., Blum W.F., and Brenner R.E. IGF-1 and IGF-2 stimulate directed cell migration of bone-marrow-derived human mesenchymal progenitor cells. Biochemical and Biophysical Research Communications 345 (2006) 1177-1183
13. Garnero P., and Delmas P.D. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. Journal of Clinical Endocrinology and Metabolism 77 (1993) 1046-1053
14. Goad D.L., Rubin J., Wang H., Tashjian A.H., and Patterson Jr. C. Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor I. Endocrinology 137 (1996) 2262-2268
15. Goff J.P. Pathophysiology of calcium and phosphorus disorders: veterinary clinics of North America. Food Animal Practice 16 (2000) 319-337
16. Hanai Y., Tokuda H., Ishisaki A., Matsushima-Nishiwaki R., Nakamura N., Yoshida M., Takai S., Ohta T., and Kozawa O. Involvement of p44/p42 MAP kinase in insulin-like growth factor-1 induced alkaline phosphatase activity in osteoblast-like-MC3T3-E1 cells. Molecular and Cellular Endocrinology 251 (2006) 42-48
17. Hauschka P.V., Mavrakos A.E., Iafrate M.D., Doleman S.E., and Klagsbrun M. Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin sepharose. Journal of Biological Chemistry 261 (1986) 12665-12674
18. He J., Rosen C.J., Adams D.J., and Kream B.E. Postnatal growth and bone mass in mice with IGF-1 haploinsufficiency. Bone 38 (2006) 826-835
19. Hill P.A., Tumber A., and Meikle M.C. Multiple extracellular signals promote osteoblast survival and apoptosis. Endocrinology 138 (1997) 3849-3858
20. Hsu Y.L., Chang J.K., Tsai C.H., Chien T.T., and Kuo P.L. Myricetin induces human osteoblast differentiation through bone morphogenetic protein-2/p38 mitogen-activated protein kinase pathway. Biochemical Pharmacology 73 (2007) 504-514
21. Ishizuya T., Yokose S., and Hori M. Parathyroid hormone exerts disparate effects on osteoblast differentiation on exposure time in rat osteoblastic cells. Journal of Clinical Investigation 99 (1997) 2961-2970
22. Jia T.L., Wang H.Z., Xie L.P., Wang X.Y., and Zhang R.Q. Daidzein enhances osteoblast growth that may be mediated by increased bone morphogenetic protein (BMP) production. Biochemical Pharmacology 65 (2003) 709-715
23. Jiang J., Lichtler A.C., Gronowicz G.A., Adams D.J., Clark S.H., Rosen C.J., and Kream B.E. Transgenic mice with osteoblast-targeted insulin-like growth factor-1 show increased bone remodeling. Bone 39 (2006) 494-504
24. Jilka R.L., Weinstein R.S., Bellido T., Parfitt A.M., and Manolagas S.C. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. Journal of Bone Mineral Research 13 (1998) 793-802
25. 2 in human osteosarcoma cell line MG-63. European Journal of Endocrinology 138 (1998) 443-448
26. Langdahl B.L., Kassem M., Moller M.K., and Eriksen E.F. The effects of IGF-1 and IGF-2 on proliferation and differentiation of human osteoblasts and interactions with growth hormone. European Journal of Clinical Investigation 28 (1998) 176-183
27. Li D.W., and Qin L.L. Effects of genistein on proliferation, differentiation, content of matrix calcium and mineralisation of cultured osteoblasts in vitro. Chinese Journal of Osteoporosis 8 (2002) 307-311
28. Li Z.X., Liu H.M., and Zhao D.S. Diagnose and treatment of osteomalacia of dairy cow. Chinese Journal of Veterinary Medicine 22 (1996) 27
29. Mackie E.J. Osteoblasts: novel roles in orchestration of skeletal architecture. The International Journal of Biochemistry and Cell Biology 35 (2003) 1301-1305
30. Malyszko J.S., Wolczynski S., and Mysliwiec M. Osteoprotegerin and its correlations with new markers of bone formation and bone resorption in kidney transplant recipients. Transplantation Proceedings 35 (2003) 2227-2229
31. Melissa, K., 2007. Calcium metabolism and metabolic bone disease. Herp Care Collection, April, 2007. http://www.anapsid.org/mbd2.html (accessed 01.04.2007).
32. Patel S., Lyons A.R., and Hosking D.J. Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use. Drugs 46 (1993) 594-617
33. Peterson W.J. A method to assess the proliferating activity of small numbers of murine peripheral blood mononuclear cells. Journal of Immunological Methods 96 (1987) 171-176
34. Sara V.R., and Hall K. Insulin-like growth factors and their binding proteins. Physiological Reviews 70 (1990) 591-614
35. Scheven B.A., Hamilton N.J., Fakkeldij T.M., and Duursma S.A. Effects of recombinant human insulin-like growth factor I and II (IGF-I/-II) and growth hormone (GH) on the growth of normal adult human osteoblast-like cells and human osteogenic sarcoma cells. Growth Regulation 1 (1991) 160-167
36. Seyedin S.M., Thomas T.C., Thompson A.Y., Rosen D.M., and Piez K.A. Purification and characterisation of two cartilage-inducing factors from bovine demineralised bone. Proceedings of the National Academy of Sciences of the USA 82 (1985) 2267-2271
37. 3 in mouse long bone interaction with the bone-derived growth factors TGF-beta and IGF-1. Journal of Bone and Mineral Research 13 (1998) 36-43
38. Suh S.J., Yun W.S., Kim K.S., Jin U.H., Kim J.K., Kim M.S., Kwon D.Y., and Kim C.H. Stimulative effects of Ulmus davidiana Planch (Ulmaceae) on osteoblastic MC3T3-E1 cells. Journal of Ethnopharmacology 109 (2007) 480-485
39. Yang Y.X., Miao Z.C., Zhang H.J., Wang Y., Gao J.X., and Feng M.F. Establishment and characterisation of a human telomerase catalytic subunit-transduced fetal bone marrow-derived osteoblastic cell line. Differentiation 75 (2007) 24-34
40. Yeh L.C.C., and Lee J.C. Co-transfection with the osteogenic protein (OP)-1 gene and the insulin-like growth factor (IGF)-1 gene enhanced osteoblastic cell differentiation. Biochimica et Biophysica Acta - Molecular Cell Research 1763 (2006) 57-63
41. Yeh L.C.C., Adamo M.L., Olson M.S., and Lee J.C. Osteogenic protein-1 and insulin-like growth factor-1 synergistically stimulate rat osteoblastic cell differentiation and proliferation. Endocrinology 138 (1997) 4181-4190
42. Zhang K.Q., Chen J.W., and Wang M.L. The expression of insulin-like growth factor-1 mRNA and polypeptide in rat osteoblasts with exposure to parathyroid hormone. Chinese Medical Journal 116 (2003) 1916-1922